Clinical outcomes with the use of sodium-glucose cotransporter-2 inhibitors in patients with atrial fibrillation and type 2 diabetes mellitus: a multicenter, real-world cohort study.
Jaehyuk JangSoYoon ParkSoohyun KimSung-Hwan KimYong-Seog OhYoung Kyoung SaYou Mi HwangSung-Won JangSang-Hyun IhmYoung ChoiPublished in: European journal of preventive cardiology (2023)
Use of SGLT2is in patients with T2DM and concomitant AF was associated with reduced mortality or HF hospitalization events.